VSee Health, Inc. (NASDAQ:VSEE) Short Interest Up 53.5% in September

VSee Health, Inc. (NASDAQ:VSEEGet Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 70,300 shares, a growth of 53.5% from the September 15th total of 45,800 shares. Based on an average daily trading volume, of 470,900 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.2% of the company’s shares are sold short. Currently, 1.2% of the company’s shares are sold short. Based on an average daily trading volume, of 470,900 shares, the days-to-cover ratio is presently 0.1 days.

VSee Health Price Performance

NASDAQ VSEE opened at $0.67 on Friday. VSee Health has a 1 year low of $0.46 and a 1 year high of $3.54. The business’s 50-day moving average is $0.68 and its 200 day moving average is $1.01.

VSee Health (NASDAQ:VSEEGet Free Report) last posted its earnings results on Wednesday, October 15th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.02). The business had revenue of $3.39 million during the quarter, compared to the consensus estimate of $3.90 million. VSee Health had a negative return on equity of 146.51% and a negative net margin of 461.61%.

Institutional Trading of VSee Health

Several large investors have recently bought and sold shares of VSEE. HB Wealth Management LLC bought a new stake in VSee Health during the 1st quarter valued at approximately $723,000. XTX Topco Ltd bought a new stake in VSee Health during the 1st quarter valued at approximately $34,000. Finally, Osaic Holdings Inc. boosted its position in VSee Health by 197.5% during the 2nd quarter. Osaic Holdings Inc. now owns 45,170 shares of the company’s stock valued at $52,000 after acquiring an additional 29,985 shares in the last quarter. 1.01% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of VSee Health in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $5.00.

Read Our Latest Analysis on VSEE

About VSee Health

(Get Free Report)

VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.

Featured Articles

Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.